All In Biotech

Drug Trial Radar · NCT07477704

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

A Randomized, Open-Label, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Weekly Alirocumab in Adults With Hypercholesterolemia

Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 438 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

438

Actual

Start

Jun 17, 2026

Primary completion

Dec 29, 2026

Study completion Feb 23, 2027

Sponsor

Lead sponsor
Regeneron PharmaceuticalsRegeneron (REGN)
Sponsor type
Industry
First posted
Mar 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the treatment of hypercholesterolemia (high blood cholesterol levels). The aim of the study is to see how safe and effective alirocumab is when given weekly to adult participants who have hypercholesterolemia. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug once a week * How much study drug is in the blood at different times

Conditions

  • Hypercholesterolemia

Interventions

  • AlirocumabDrug

    Administered per the protocol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent change in LDL-CTime frame: From Baseline through Week 12

Locations

34 sites in 1 country. Site status is shown where the registry gives one.

  • Pinnacle Research Group

    Anniston, Alabama

  • Cullman Clinical Trials

    Cullman, Alabama

  • Anaheim Clinical Trials

    Anaheim, California

  • Cenexel CNS

    Los Alamitos, California

  • Diablo Clinical Research - Flourish Research

    Walnut Creek, California

  • Tampa Bay Medical Research

    Clearwater, Florida

  • Southwest General Healthcare Center

    Fort Myers, Florida

  • Precision Clinical Research

    Sunrise, Florida

  • K2 Medical Research The Villages

    The Villages, Florida

  • Center for Advanced Research and Education

    Gainesville, Georgia

  • Balanced Life Health Care Solutions

    Lawrenceville, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • L-MARC Research Center

    Louisville, Kentucky

  • Tandem Clinical Research

    Marrero, Louisiana

  • Mercury Street Medical Group, PLLC

    Butte, Montana

  • Velocity Clinical Research - Omaha

    Omaha, Nebraska

  • Palm Research Center, Mountainview Medical Center

    Las Vegas, Nevada

  • Velocity Clinical Research - Durham

    Durham, North Carolina

  • Accellacare of Wilmington

    Wilmington, North Carolina

  • Ohio Clinical Trials

    Columbus, Ohio

  • AMR Norman

    Norman, Oklahoma

  • Lynn Health Science Institute

    Oklahoma City, Oklahoma

  • Velocity Clinical Research, Medford

    Medford, Oregon

  • Altoona Center for Clinical Research

    Duncansville, Pennsylvania

  • Tribe Clinical Research

    Greenville, South Carolina

  • Coastal Carolina Research Center_North Charleston

    North Charleston, South Carolina

  • Velocity Clinical Research Dallas

    Dallas, Texas

  • Valley Institute of Research, Rockwood Medical Clinic

    Fort Worth, Texas

  • Be Well Clinical Studies - Round Rock

    Round Rock, Texas

  • Flourish Research, Legacy Oaks Tower

    San Antonio, Texas

  • Endeavor Clinical Trials

    San Antonio, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • Charlottesville Medical Research

    Charlottesville, Virginia

  • Rainier Clinical Research Center

    Renton, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.